Log In
Print this Print this

Cinaciguat (BAY 58-2667)

  Manage Alerts
Collapse Summary General Information
Company Bayer AG
DescriptionSoluble guanylate cyclase activator
Molecular Target Soluble guanylate cyclase (sGC)
Mechanism of ActionGuanylate cyclase activator
Therapeutic Modality 
Latest Stage of DevelopmentPhase II
Standard IndicationHeart failure
Indication DetailsTreat acute heart failure
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today